天津医药产业政策（闭门）交流研讨会

Dear Members and Friends of SwissCham,

天津——中国生物医药创新高地，开放合作共赢未来！

天津拥有国家级生物医药产业集群，覆盖放药、医疗器械、合成生物、创新药、疫苗等全领域，全链条支持生物医药创新发展。依托京津冀协同发展，天津坐拥丰富的产业人才、临床与研发资源和头部企业聚集，打造"研发-临床-制造"一体化生态。

天津港保税区拥有"空港+海港", "自贸+保税"发展优势赋能医药产业，提供进口设备耗材保税、运输通关便利、跨境研发支持，加速企业国际化布局。

天津市科学技术局、天津市投资促进局、天津港保税区，携手中国德国商会，中国瑞士商会特邀您于4月28日参加"天津医药产业政策（闭门）交流研讨会"，共享医药产业发展新机遇！

语言：中文

Language: Chinese

Tianjin - a highland of innovation in China's biopharmaceutical industry, open cooperation and win-win future!

Tianjin has a national level biopharmaceutical industry cluster, covering all fields such as pharmaceuticals, medical devices, synthetic biology, innovative drugs, vaccines, etc., supporting the innovation and development of biopharmaceuticals throughout the entire chain. Relying on the coordinated development of Beijing Tianjin Hebei, Tianjin has abundant industrial talents, clinical and research and development resources, and a gathering of leading enterprises, creating an integrated ecosystem of "research and development clinical manufacturing".

Tianjin Port Free Trade Zone has the advantages of "airport+port" and "free trade+bonded" development, which empowers the pharmaceutical industry. It provides bonded import equipment and consumables, convenient transportation and customs clearance, cross-border research and development support, and accelerates the internationalization layout of enterprises.

Tianjin Port Free Trade Zone, together with the German Chamber of Commerce in China, the Swiss Chamber of Commerce in China, and the Tianjin Science and Technology Bureau, invites you to participate in the "Tianjin Pharmaceutical Industry Policy (Closed Door) Exchange Seminar" on April 28 to share new opportunities for the development of the pharmaceutical industry!

**注意事项please note

• 此会议为闭门会议，仅面向医药产业相关会员开放。 This is a closed-door meeting exclusively open to members from the pharmaceutical industry.
• 如您有活动相关问题可联系孟蕾女士: lei.meng@swisscham.org. If you have any questions, please feel free to contact Ms. Meng Lei at lei.meng@swisscham.org

With best regards,

Your SwissCham Team